CEO has accepted a new role at the Prince’s Trust
RCVS chief executive Nick Stace will leave the college at the end of the summer and begin a new role as UK chief executive at The Prince’s Trust.
Mr Stace has led the college through a period of great change since joining in 2012. During his tenure the college introduced a new Royal Charter and became the official regulator for veterinary nurses. It has also seen major governance reform, a relaunch of the Practice Standards Scheme and the launch of Mind Matters and Vet Futures.
Commenting on his time at the college, Mr Stace described it as a “privilege” to work with RCVS staff, a “progressive” council and a “decent and caring profession”.
He added: “I hope I have played my part in helping the College and the profession navigate through a period of great change and preparation for significant change to come.”
The Prince’s Trust, where Mr Stace will start work in October, ‘creates life-changing opportunities’ for young people aged 11-30. The charity says it plans to extend its work to reach more than 70,000 young people a year.
“At The Prince’s Trust I will be focused on the next generation,” he explained, “helping to give young people the confidence and purpose they need to make a success of their lives and the world around them. I know from my own personal experiences of school, and the various charities with which I have been involved, how many young people are not given the best chance in life. I cannot think of a better mission to take on.”
RCVS president Chris Tufnell said Mr Stace has “infused the college with a culture of openness, engagement and dedication”.
He added: “There’s a considerable amount of important work being done by the RCVS and I am confident that we have a strong team at Belgravia House to manage this until the new CEO is in post.”
The operational board will develop a specification for a new CEO and the recruitment process will take place over the coming weeks.
Image courtesy of the RCVS
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
